Clinical Trial Update: Neoadjuvant Temozolomide Combined With Simultaneous IMRT for Treatment of Glioblastoma [Phase 3]

View source ↗

Summary

Phase 3 trial investigating neoadjuvant temozolomide with simultaneous IMRT for glioblastoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• IMRT
• Temozolomide (Temozolomide)

Snippet

Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | Conditions: Glioblastoma | Phase 3 | Status: UNKNOWN